Determinants of Cervical Cancer Screening Uptake Among Antenatal Women in a Semi-Urban Hospital in Ebonyi State, Nigeria.
Main Article Content
Keywords
Cervical cancer, screening, motivators, barriers, uptake
Abstract
Background: Cervical cancer remains a major cause of cancer-related morbidity and mortality, especially among rural and semi-urban women in developing countries. Cervical cancer screening is a cost-effective method of detecting premalignant lesions of the cervix. The study aims to assess the practice and determinants of cervical cancer screening among women attending antenatal clinics in a semi-urban town of Ebonyi State.
Methodology: The study was a cross-sectional study. Three hundred and ninety-six eligible participants were serially selected in the antenatal clinic. Data was analyzed using IBM-SPSS version 21.0. Percentages of the data were expressed. Chi-square was used to test for the level of significance, and P-values of < 0.05 were considered significant.
Results: Majority had heard about cervical cancer, 75.2% of them had heard about the screening, and 66.8% of them believed that cervical cancer is preventable. The majority of the women who heard about cervical cancer have never been screened. Knowing that cervical screening was important was the major motivator in 46.8% of the women, while not knowing where to go for the screening was the major barrier. There is a significant relationship between the number of children had by the respondents and the level of uptake of the cervical cancer screening (P<0.05).
Conclusion: There was poor uptake of cervical cancer screening among the respondents despite commendable knowledge about cervical cancer and screening. Screening should be widely available in semi-urban areas and should be effectively incorporated into other existing health services.
References
2. Dim CC. Towards improving cervical cancer screening in Nigeria: A review of the basics of cervical neoplasm and cytology. Niger J Pract. 2012; 15: 247-52
3. Marcel-Onwudiwe CS, Esike COU, Agwu MU, Adebayo JA, Nweke AN, Uzoigwe JC, Uche-Omovoh IC, Uwakwe EC. Comparison of Papanicolaou Smear Tests Among HIV Negative and HIV Positive Pregnant Women on HAART at a Tertiary Hospital. Niger Med J. 2025;65(6):1070-1079.
4. World Health Organisation, Geneva, Switzerland,2015. Available from: http://www.afro.who.int/en/clusters-a-programmes/dpc/non-communicable-disease-management/ndm/programm-components/cancer. (Accessed 11/11/2020)
5. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN Estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA:Cancer J Clin.2018;68:394-424
6. Sowemimo OO, Ojo OO, Fasuba OB. Cervical cancer screening and practice in low resource countries: Nigeria as a case study. Trop J ObstetGynaecol. 2017;34:170-6
7. Idowu A, Olowookere, S, Fagbemi A, Ogunlaja O. Determinants of cervical cancer screening uptake among women in Ilorin, North central Nigeria: A community based study. J Cancer Epi 2016;2016:646920
8. Eze JN, Umeora OU, Obuna JA, Egwuatu VE, Ejikeme BN. Cervical cancer awareness and cervical screening uptake at the Mater Misericordiae Hospital, Afikpo, South east Nigeria. Ann Afr Med 2012;11:238-43
9. Adegboyega A, Aleshir M, Linares AM. Examining.cervical cancer screening utilization among African immigrant women. A literature review. Int J Women Health Wellness.2017;3-46
10. Mahmood IS. Premalignant and malignant disease of the cervix . In: Edmonds K.D (ed); Dewhurst’s Textbook of Obstetrics and Gynaecology 8th edition. London. Wiley-Blackwell publishing ltd 2012; 747-759
11. Pourhoseingholi MA, Vahedi M, Rahimzadeh M. Sample size calculations in medical studies. GastroenteroHepatol Bed Bench. 2013;6(1):14-17
12. Ijezie AE, Johnson OE. Knowledge of cervical cancer and the uptake of the Papanicolaou smear test among public secondary school teachers in Akwaibom, Nigeria. Niger Med J. 2019;60(5):245-251
13. Eze GU, Obiebi IP, Umuago IJ. Perspective of cervical cancer and screening practices
14. Ingwu J. Knowledge and screening practices of cervical cancer among pregnant women attending antenatal clinic in Tertiary Hospitals in Enugu, Southeast Nigeria. J Ca Tumor Int. 2016;4:1-9
15. Urom GI, Omaba EO, Okoli NJ, Eze NS, Azuogu BN, Umeora OU. Cervical cancer: Risk factors and uptake of screening among expectant mothers in Abakaliki. Niger J Surg Sci 2017;27:37-40
16. Enebe J, Enebe NO, Eze FO, Ajah L, Ajah M, Nweze SO. The awareness and uptake of cervical screening among female nurses in Enugu, Southeast Nigeria. TIJPH. 2013;8:2.
Available @ https://www.texilajournal.com/public-health/article/1669-the-awarenessand-uptake-of-cervical-cancer-screening-amaong-female-nurses-in-Enugu-sout-east-Nigeria. (Accessed on 12/11/2020)
17. Okonuwo AA, Smith-Okonu ST. Cervical cancer screening among urban women in Lagos, Nigeria. Focus on barriers and motivators for screening. Niger J Gen Pract. 2020;18:10-16
18. Ndikom CM, Ofi BA. Awareness, Perception and factors affecting utilization of cervical cancer screening services among women in Ibadan, Nigeria: a qualitative study. Reprod Health.2012;9:11
19. Olubodun T, Odukoya OO, Balogun MR. Knowledge, attitude and practice of cervical cancer prevention among women residing in urban slum in Lagos, southwest, Nigeria. Pan Afr Med J. 2019;32:130
20. Rimande–Joel R, Ekenedo G. Knowledge, Belief and practice of cervical cancer screening and prevention among women of Taraba, North East Nigeria. Asian Pac J Cancer Prev. 2019;20(11):3291-98
21. Nwobodo H, Ba-Break M. Analysis of the determinants of low cervical cancer screening uptake among Nigerian women. J Pub Health Afri. 2015;6(486):12-19
22. Mbachu C, Dim C, Ezeoke U. Effects of peer health education on perception and practice
of screening for cervical cancer among urban residential women in South-east Nigeria: a
before and after study. BMC Women’s Health.2017;17:14
23. Ilevbare OE, Adegoke AA, Adelowo CM. Drivers of cervical cancer screening uptake in Ibadan, Nigeria. Heliyon. 2020;6(3):e03505.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
This is an open-access journal and articles are distributed under the terms of the Creative Commons Attribution Non-Commercial Share-Alike License 4.0. This licence allows users to download and share, remix, tweak and build upon the article for non-commercial purposes, so long as the original authorship is acknowledged and the new creations are licensed under identical terms.